2026-01-18 - Analysis Report
**Company Overview**
UnitedHealth Group Inc is a diversified health care company that provides medical coverage to millions of people worldwide.

**Return Rate Comparison**
- Cumulative return of UNH: **-21.52%**
- Cumulative return of VOO: **93.36%**
- Degree of divergence: **-113.20**

**Alpha, Beta Analysis**
- **| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |**
- **|------------|------|------|-------|------|-------|**
- **| 2016-2018  | 22.0% | 18.6% | 19.0% | 0.9 | 225.7B |**
- **| 2017-2019  | 27.0% | 18.6% | 10.0% | 0.9 | 266.3B |**
- **| 2018-2020  | -41.0% | 32.5% | -62.0% | 1.1 | 317.7B |**
- **| 2019-2021  | 16.0% | 32.5% | -27.0% | 1.1 | 454.9B |**
- **| 2020-2022  | 0.0% | 31.5% | 2.0% | 0.9 | 480.3B |**
- **| 2021-2023  | 23.0% | 13.4% | 23.0% | 0.5 | 476.9B |**
- **| 2022-2024  | -24.0% | 23.1% | -44.0% | 0.4 | 458.2B |**
- **| 2023-2025  | -55.0% | 58.5% | -118.0% | 0.3 | 299.0B |**

**Recent Stock Price Fluctuation**
- Close: **$331.02**
- Last-market: {'price': 331.02, 'previousClose': 338.96, 'change': **-2.34%**}
- 5-day SMA: **$335.88**
- 20-day SMA: **$334.77**
- 60-day SMA: **$333.81**

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**
- Market Risk Indicator (MRI): **0.80**
- RSI: **49.38**
- PPO: **-0.17**
- Hybrid Signal: Buy (Cash 0%)
- Risk Level: Medium (MRI 0.80)
- Recent (20 days) relative divergence change: **-1.70 (-)**
- 7-day Rank change: **-94 (-)**
- 7-day Dynamic Expected Return change: **-23.20 (-)**
- Expected Return: **-297.90%**

**News & Significant Events**
- [2026-01-16] ‘Top Healthcare Pick for 2026,’ Says Bernstein on UnitedHealth Stock (UNH). Here’s Why - TipRanks (news.google.com)
- [2026-01-15] UnitedHealth Faces New Medicare Accusations. What Does That Mean for UNH Stock? - Yahoo Finance (news.google.com)
- [2026-01-14] Is UnitedHealth Group Stock a Buy, Sell, or Hold in 2026? - The Motley Fool (news.google.com)
- [2026-01-15] As Trump Unveils His ‘Great Healthcare Plan,’ How Should You Play UnitedHealth Stock? - Barchart.com (news.google.com)
- [2026-01-16] Trump Just Took Aim at Health Insurance ‘Middlemen.’ What Does That Mean for UnitedHealth Stock? - Yahoo Finance (news.google.com)
- [2026-01-14] UnitedHealth Just Got a Checkup, and UNH Stock Has Some Big Problems to Treat in 2026. The Bull and Bear Cases Now. - Yahoo Finance (news.google.com)

**Analyst Opinions**
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): **1.93**
  - Opinions: **26**
  - Target Price (avg/high/low): **$393.85 / $444.00 / $280.00**

**Recent Earnings Analysis**
- **| Date | EPS | Revenue |**
- **| 2025-10-28 | $2.59 | $113.16 B$ |**
- **| 2025-08-11 | $3.76 | $111.62 B$ |**
- **| 2025-05-07 | $6.9 | $109.58 B$ |**
- **| 2024-11-04 | $6.56 | $100.82 B$ |**
- **| 2025-10-28 | $6.56 | $100.82 B$ |**

**Revenue and Profitability**
- **| Quarter | Revenue | Profit Margin |**
- **| 2025-09-30 | $113.16B | 18.24% |**
- **| 2025-06-30 | $111.62B | 17.93% |**
- **| 2025-03-31 | $109.58B | 21.70% |**
- **| 2024-12-31 | $100.81B | 21.14% |**
- **| 2024-09-30 | $100.82B | 22.84% |**

**Capital and Profitability**
- **| Quarter | Equity | ROE |**
- **| 2025-09-30 | $95.79B | 2.45% |**
- **| 2025-06-30 | $94.72B | 3.60% |**
- **| 2025-03-31 | $95.04B | 6.62% |**
- **| 2024-12-31 | $92.66B | 5.98% |**
- **| 2024-09-30 | $94.53B | 6.41% |**

**Comprehensive Analysis**
UnitedHealth Group Inc showed a cumulative return of -21.52% compared to the S&P 500's 93.36%. The company's recent stock price fluctuated slightly, with a 5-day, 20-day, and 60-day moving average of $335.88, $334.77, and $333.81, respectively. The RSI and PPO index indicators suggested a neutral market risk, while the Delta_Previous_Relative_Divergence and Expected_Return indicated a potential sharp rebound or decline. Recent news and significant events showed mixed sentiments, with some analysts recommending a buy and others a sell or hold. The analyst consensus recommended a buy, with a mean rating of 1.93. Recent earnings analysis showed a mixed trend, with EPS and revenue fluctuating around $2.59 and $113.16B, respectively. The company's revenue and profitability showed a slight increase in recent quarters, while capital and profitability indicated a stable Equity and ROE.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.